Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded May 29, 2026 · Filed Jun 2, 2026
Zimmer Biomet's Group President, Asia Pacific sold $347K of Zimmer Biomet shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$347,088
Shares × reported transaction price
31 days after results of Apr 28, 2026, 68 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $82.33 on May 29, 2026, within 4% of its 52-week low, after a 13% drop over the previous 30 trading days
52-week range $79.58 (May 11, 2026) to $107.71 (Aug 22, 2025), 10% of the way up, from 251 adjusted closes. 30 trading days earlier: $94.78 on Apr 16, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.8% | -3.8% | +7.6% |
| 30 days | +5.6% | -0.4% | +6.0% |
| 90 days | +17.0% | +1.0% | +16.0% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.